NGNE · Nasdaq
It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.
Hover or tap a dot to see the filings behind that score.
Neurogene Inc. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal period ended September 30, 2024 (the “10-Q”) within the time period prescribed. While the Company has substantially completed the preparation of the 10-Q, the Company is experiencing delays due to recent developments that have diverted significant management time and internal resources from the Company's process for reviewing and completing its financial statements and related disclosures. As a result of these delays, the Company requires additional time to finalize for adequate disclosure of the information to be included in the 10-Q. The Company expects to finalize its review of and to file the 10-Q on or before the fifth calendar day following the prescribed due date. Cautionary Statement Concerning Forward-Looking Statements This Form 12b-25 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “will,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the beliefs and expectations of the Company’s management relating to the timing of the filing of the 10-Q. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company’s control. Important factors that may cause actual results to differ materially from those in the forward-looking statements include a material delay in the Company’s ability to file the 10-Q due to the additional time required to complete the review process for financial statements and related disclosures
NT 10-Q, filed 2024-11-14 · investigation
Neurogene Inc. (the “Company”) has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the fiscal period ended September 30, 2024 (the “10-Q”) within the time period prescribed. While the Company has substantially completed the preparation of the 10-Q, the Company is experiencing delays due to recent developments that have diverted significant management time and internal resources from the Company's process for reviewing and completing its financial statements and related disclosures. As a result of these delays, the Company requires additional time to finalize for adequate disclosure of the information to be included in the 10-Q. The Company expects to finalize its review of and to file the 10-Q on or before the fifth calendar day following the prescribed due date. Cautionary Statement Concerning Forward-Looking Statements This Form 12b-25 contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “expect,” “will,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the beliefs and expectations of the Company’s management relating to the timing of the filing of the 10-Q. These forward-looking statements are not guarantees of future results and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company’s control. Important factors that may cause actual results to differ materially from those in the forward-looking statements include a material delay in the Company’s ability to file the 10-Q due to the additional time required to complete the review process for financial statements and related disclosures
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice